Comparison of Ethinyl-Estradiol Plus Cyproterone AcetateVersusMetformin Effects on Classic Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome-Reference-Cited by-同舟云学术

Comparison of Ethinyl-Estradiol Plus Cyproterone AcetateVersusMetformin Effects on Classic Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome

Published:2007-07-01 Issue:7 Volume:92 Page:2453-2461
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Luque-Ramírez Manuel¹,Álvarez-Blasco Francisco¹,Botella-Carretero José I.¹,Martínez-Bermejo Elena¹,Lasunción Miguel A.²³,Escobar-Morreale Héctor F.¹

Affiliation:

1. Departments of Endocrinology (M.L.-R., F.A.-B., J.I.B.-C., E.M.-B., H.F.E.-M.), Hospital Universitario Ramón y Cajal and Universidad de Alcalá, E-28034 Madrid, Spain

2. Department of Centro de Investigación Biomédica en Red (CIBER) Fisiopatologia Obesidad y Nutrición (CB06/03) (M.A.L.), Instituto de Salud Carlos III, E-28029 Madrid, Spain

3. Department of Biochemistry-Research (M.A.L.), Hospital Universitario Ramón y Cajal and Universidad de Alcalá, E-28034 Madrid, Spain

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/92/7/2453/11059078/jcem2453.pdf

Reference47 articles.

1. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.;Asuncion;J Clin Endocrinol Metab,2000

2. Prevalence, definition and clinical manifestations of polycystic ovary syndrome;Diamanti-Kandarakis;Endocrinol Nutr,2006

3. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline.;Azziz;J Clin Endocrinol Metab,2006

4. The molecular-genetic basis of functional hyperandrogenism and polycystic ovary syndrome.;Escobar-Morreale;Endocr Rev,2005

5. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome.;Nelson;J Clin Endocrinol Metab,2001

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study;International Journal of Endocrinology;2022-03-19

2. Effect of Oral Contraceptive Pill and Metformin on Metabolic and Endocrine Parameters in Polycystic Ovarian Syndrome: A Prospective Interventional Study;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2022

3. Combined oral contraceptives: Why, when, where?;Polycystic Ovary Syndrome;2022

4. Cardiovascular Side Effects of Medications for Skin Diseases;Skin and the Heart;2021

5. A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy;Expert Opinion on Drug Safety;2020-11-05